Nvidia And Intel’s Leap Into AI Chips: What It Means For Your Investments
As we usher in a new era of technological innovation in 2024, Benzinga is at the forefront, hosting…
Alibaba.com Introduces New AI-Powered Feature At CES To Boost Efficiency And Growth For SMEs And Entrepreneurs In 2024
Along with new AI features introduced to the global sourcing platform's Smart Assistant, Alibaba.com highlights commitment to the entrepreneurial spirit with new Entreprenuts campaignNEW YORK, Jan. 9, 2024 /PRNewswire/
TFF Pharmaceuticals Announces Acceptance Of Late-Breaking Abstract For Presentation At The 44th Annual International Society For Heart And Lung Transplantation 2024 Meeting
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology
Mining Milestone: Rio Tinto To Launch World’s Largest Project In Guinea’s Simandou Mountains
Exploring Rio Tinto's groundbreaking $6.2 billion Simandou project in Guinea, set to become the world's largest mining venture amidst decades of challenges.
Twitch, OBS And NVIDIA To Release Multi-Encode Livestreaming; Twitch Enhanced Broadcasting Beta Enables Multiple Concurrent Streams To Twitch From A Single GeForce PC; Stream Beginning Shortly On NVIDIA Twitch Channel
https://blogs.nvidia.com/blog/twitch-multiencode-av1-livestreaming/https://www.twitch.tv/nvidia Twitch, OBS and NVIDIA are leveling up livestreaming technology with the new Twitch Enhanced Broadcasting beta, powered
WISeKey And SEALSQ To Showcase Its Security Services And Semiconductors For IoT Device Manufacturers Adopting The Matter Protocol At CES 2024
January 8, 2023: WISeKey International Holding Ltd. ("WISeKey") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, today
Summit Therapeutics Announces Updated Phase II Data For Ivonescimab At 42nd Annual J.P. Morgan Healthcare Conference
Phase II 24-Month OS Rate of 64.8% in 1L Squamous NSCLC PatientsPhase II mOS of 22.5 Months in 2L+ EGFRm, TKI-progressed NSCLC PatientsCatalyst Events Expected in Q2 2024 for Two Randomized Phase III Trials Evaluating
Incyte Highlights Growth Opportunities And Provides Business Updates At The 42nd Annual J.P. Morgan Healthcare Conference
Presentation underscores potential of several high-impact launches across Oncology and Inflammation & Autoimmunity to drive sustainable long-term growthCompany announces new positive topline results from Phase 2
Innoviz To Showcase All-New BMW i7 And Volkswagen ID. Buzz At CES Booth; LiDAR Capabilities Will Be Demonstrated
New Volkswagen ID. Buzz with InnovizTwo LiDAR to be shown at Innoviz booth (#6252) and Mobileye booth (#4600)2024 BMW i7 with InnovizOne LiDAR is now available for order in GermanyTEL AVIV, Israel , Jan.
Editas Medicine Highlights 2024 Anticipated Milestones And Strategic Priorities At The J.P. Morgan Healthcare Conference
Anticipated 2024 milestones include: present reni-cel clinical data updates mid-year and year-end, initiate the RUBY clinical trial adolescent cohort, establish in vivo preclinical proof-of-concept for an undisclosed